Genomic gains on chromosome 1q in retinoblastoma: Consequences on gene expression and association with clinical manifestation

International Journal of Cancer

Volumn 116, Issue 4, 2005, Pages 555-563

  Gratias, Sandrine ^a   Schüler, Andreas ^a   Hitpass, Ludger Klein ^a   Stephan, Harald ^a   Rieder, Harald ^b,c   Schneider, Stephanie ^b   Horsthemke, Bernhard ^a   Lohmann, Dietmar R ^a,d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Amplification 1q; Candidate gene; Microarray; Quantitative multiplex PCR; Retinoblastoma

Indexed keywords

COMPLEMENTARY DNA; DNA; RNA;

ALLELISM; ARTICLE; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME 6P; CLINICAL FEATURE; DNA DETERMINATION; DNA HYBRIDIZATION; DNA MICROARRAY; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RB1 GENE; RETINOBLASTOMA; RNA ANALYSIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RETINAL NEOPLASMS; RETINOBLASTOMA; RNA;

EID: 23244433777     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21051     Document Type: Article

References (48)

1. Moll AC, Kuik DJ, Bouter LM, Den Otter W, Bezemer PD, Koten JW, Imhof SM, Kuyt BP, Tan KE. Incidence and survival of retinoblastoma in the Netherlands: a register based study 1862-1995. Br J Ophthalmol 1997;81:559-62.
2. Suckling RD, Fitzgerald PH, Stewart J, Wells E. The incidence and epidemiology of retinoblastoma in New Zealand: a 30-year survey. Br J Cancer 1982;46:729-36.
3. Devesa SS. The incidence of retinoblastoma. Am J Ophthalmol 1975; 80:263-5.
4. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987;329:642-5.
5. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987;236:1657-61.
6. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323:643-6.
7. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-84.
8. Classon M, Harlow E. The retinoblastoma tumor suppressor in development and cancer. Nature Rev Cancer 2002;2:910-7.
9. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 1999;59(Suppl 7):1731s-35s.
10. Oliveros O, Yunis E. Chromosome evolution in retinoblastoma. Cancer Genet Cytogenet 1995;82:155-60.
11. Cowell JK, Hogg A. Genetics and cytogenetics of retinoblastoma. Cancer Genet Cytogenet 1992;64:1-11.
12. Potluri VR, Helson L, Ellsworth RM, Reid T, Gilbert F. Chromosomal abnormalities in human retinoblastoma. A review. Cancer 1986;58: 663-71.
13. Squire J, Phillips RA, Boyce S, Godbout R, Rogers B, Gallic BL. Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum Genet 1984;66:46-53.
14. Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 1985;70:291-301.
15. Mairal A, Pinglier E, Gilbert E, Peter M, Validire P, Desjardins L, Doz F, Aurias A, Couturier J. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 2000;28:370-9.
16. Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, Young BD, Onadim Z. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 2003;36:121-8.
17. Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2001;129:57-63.
18. Herzog S, Lohmann DR, Buiting K, Schuler A, Horsthemke B, Rehder H, Rieder H. Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 2001;108:98-104.
19. Almeida A, Zhu XX, Vogt N, Tyagi R, Muleris M, Dutrillaux AM, Dutrillaux B, Ross D, Malfoy B, Hanash S. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene 1998;16:2997-3002.
20. Bornfeld N, Lommatzsch PK, Havers W, Schüler A. Retinoblastoma. In: Lommatzsch PK, ed. Ophthalmologische onkologie. Stuttgart: Enke, 1999.329-60.
21. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 1977;37:1003-10.
22. Gallie BL, Albert DM, Wong JJ, Buyukmihci N, Pullafito CA. Heterotransplantation of retinoblastoma into the athymic "nude" mouse. Invest Ophihalmol Vis Sci 1977;16:256-9.
23. Griegel S, Hong C, Frotschl R, Hulser DF, Greger V, Horsthemke B, Rajewsky MF. Newly established human retinoblastoma cell lines exhibit an "immortalized" but not an invasive phenotype in vilro. Int J Cancer 1990;46:125-32.
24. Richter S, Vandczande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-69.
25. Riemenschneider MJ, Buschges R, Wolter M, Reifenberger J, Bostrom J, Kraus JA, Schlegel U, Reifenberger G. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 1999;59:6091-6.
26. Riemenschneider MJ, Knobbe CB, Reifenberger G. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int J Cancer 2003;104:752-7.
27. Baugh LR, Hill AA, Brown EL, Hunter CP. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001;29:E29.
28. Durig J, Nuckel H, Huttmann A, Kruse E, Holler T, Halfmeyer K, Fuhrer A, Rudolph R, Kalhori N, Nusch A, Deaglio S, Malavasi F, et al. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 2003;101:2748-55.
29. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
30. Evans AJ, Gallie BL, Jewett MA, Pond GR, Vandezande K, Underwood J, Fradet Y, Lim G, Marrano P, Zielenska M, Squire JA. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am J Pathol 2004;164:285-93.
31. Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, Gallie BL. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like sene, RBKIN. Cancer Res 2002;62:967-71.
32. Horsthemke B. Genetics and cytogenetics of retinoblastoma. Cancer Genet Cytogenet 1992;63:1-7.
33. Abramson DH, Ellsworth RM, Zimmerman LE. Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:454-7.
34. Francois J. Retinoblastoma and osteogenic sarcoma. Ophthalmologica 1977;175:185-91.
35. Matsunaga E. Hereditary retinoblastoma: host resistance and second primary tumors. J Natl Cancer Inst 1980;65:47-51.
36. Li FP, Abramson DH, Tarone RE, Klemerman RA, Fraumeni JF Jr, Boice JD Jr. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst 1997;89:83-4.
37. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121-8.
38. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 2004;109:363-9.
39. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998;152: 1107-23.
40. Lau CC, Harris CP, Lu XY, Perlaky L, Gogineni S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos AG, Meyers PA, Healy JH, et al. Frequent amplification and rearrangement of chromosomal bands 6pl2-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004;39:11-21.
41. Pimkhaokham A, Shimada Y, Fukuda Y, Kurihara N, Imoto I, Yang ZQ, Imamura M, Nakamura Y, Amagasa T, Inazawa J. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn J Cancer Res 2000;91:1126-33.
42. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163: 1033-43.
43. de la Guardia C, Casiano CA, Trinidad-Pinedo J, Baez A. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 2001;23:104-12.
44. Rassidakis GZ, Lai R, McDonnell TJ, Cabanillas F, Sarris AH, Medeiros LJ. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol 2002;160:2309-10.
45. Cho-Vega JH, Rassidakis GZ, Admirand JH, Oyarzo M, Ramalingam P, Paraguya A, McDonnell TJ, Amin HM, Medeiros LJ. MCL-1 expression in B-cell non-Hodgkin's lymphomas. Hum Pathol 2004; 35:1095-100.
46. Bae J, Leo CP, Hsu SY, Hsueh AJ. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 2000;275: 25255-61.
47. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62: 6240-5.
48. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer R4es 1994;54:4299-303.